Citations

Showing 10 of 108094 citations.

Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments
Reiman, Eric M. , Fleisher, Adam , Caselli, Richard J. , Chen, Kewei , Ayutyanont, Napatkamon , Quiroz, Yakeel T. , Tariot, Pierre N. , Langbaum, Jessica B. S. , Kosik, Kenneth S. , Lopera, Francisco Javier

Mayo Clinic

Journal of Alzheimer's Disease | May 16, 2018 | Volume: 26 | Issue: s3 | Pages: 321-329

10.3233/jad-2011-0059 | PMID 21971471 Get It

Replication of BIN1 Association with Alzheimer's Disease and Evaluation of Genetic Interactions
Carrasquillo, Minerva M. , Belbin, Olivia , Hunter, Talisha A., Bisceglio, Gina, Zou, Fanggeng, Sando, Sigrid Botne , Aasly, Jan , Barcikowska, Maria , Dickson, Dennis W. , Graff‐Radford, Neill R. , Petersen, Ronald C. , Morgan, Kevin , Younkin, Steven G., Kehoe, Patrick G. , Belbin, Olivia , Dickson, Dennis W , Carrasquillo, Minerva M. , Ma, Li , Crook, Julia E. , Pankratz, V. Shane , Wszołek, Zbigniew K.

Mayo Clinic

Journal of Alzheimer’s Disease | May 16, 2018 | Volume: 24 | Issue: 4 | Pages: 751-758

10.3233/jad-2011-101932 | PMID 21321396 Get It

The most recent late-onset Alzheimer's disease (LOAD) genome-wide association study revealed genome-wide significant association of two new loci: rs744373 near BIN1 (p = 1.6 × 10 −11 ) and rs597668 near EXOC3L2/BLOC1S3/MARK4 (p = 6.5 × 10 −9 ). We have genotyped these variants in a large (3,287 LOAD, 4,396 controls), independent dataset comprising eleven case-control series from the USA and Europe. We performed meta-analyses of the association of these variants with LOAD and also tested for association using logistic regression adjusted by age-at-diagnosis, gender, and APOE ε4 status. Meta-analysis results showed no evidence of series heterogeneity and logistic regression analysis successfully replicated the association of BIN1 (rs744373) with LOAD with an odds ratio (OR = 1.17, p = 1.1 × 10 −4 ) comparable to that previously reported (OR = 1.15). The variant near EXOC3L2 (rs597668) showed only suggestive association with LOAD (p = 0.09) after correcting for the presence of the APOE ε4 allele. Addition of our follow-up data to the results previously reported increased the strength of evidence for association with BIN1 (11,825 LOAD, 32,570 controls, rs744373 Fisher combined p = 3.8 × 10 −20 ). We also tested for epistatic interaction between these variants and APOE ε4 as well as with the previously replicated LOAD GWAS genes (CLU: rs11136000, CR1: rs3818361, and PICALM: rs3851179). No significant interactions between these genes were detected. In summary, we provide additional evidence for the variant near BIN1 (rs744373) as a LOAD risk modifier, but our results indicate that the effect of EXOC3L2 independent of APOE ε4 should be studied further.
Heritability of Different Forms of Memory in the Late Onset Alzheimer's Disease Family Study
Barral, Sandra , Lee, Joseph H. , Bird, Thomas D., Mayeux, Richard , Bennett, David A. , Wilson, Robert S. , Bennett, David A. , Wilson, Robert S., Leurgans, Sue E. , Foroud, Tatiana , Sweet, Robert A. , Graff, Caroline

Mayo Clinic

Journal of Alzheimer's Disease | May 16, 2018 | Volume: 23 | Issue: 2 | Pages: 249-255

10.3233/jad-2010-101515 | PMID 20930268 Get It

Bacterial Contamination of a Marking Pen in Anterior Cruciate Ligament Reconstruction
Ridley, Taylor J. , Rud, Christopher T., Krych, Aaron J. , Macalena, Jeffrey A. , Krych, Aaron J , Macalena, Jeffrey A

Mayo Clinic

Orthopaedic Journal of Sports Medicine | May 16, 2018 | Volume: 6 | Issue: 5 | Pages: No page available

10.1177/2325967118772043 | PMID 29796399 Get It

Background: A sterile surgical marking pen is commonly used during anterior cruciate ligament reconstruction (ACLR) to outline the proposed skin incision and then to mark the graft during preparation. Once in contact with the skin, the pen is a potential source of bacterial transmission and subsequent infections after ACLR. Purpose/Hypothesis: The purpose of this study was to assess whether the skin marking pen is a fomite for contamination during arthroscopic ACLR. We hypothesized that there would be a difference in the rate of culture-positive pens between control pens and the study pens used to delineate the proposed skin incision. Study Design: Controlled laboratory study. Methods: Twenty surgical marking pens were collected prospectively from patients undergoing ACLR over a 12-month period. All patients underwent standard preoperative sterile preparation and draping procedures. Proposed incisions were marked with a new sterile pen, and the pen tip was immediately sent for a 5-day inoculation in broth and agar. Negative controls (unopened new pen) and positive controls (used to mark the skin incisions preoperatively) were also cultured. Additionally, blank culture dishes were observed during the growth process. All pens were removed from the surgical field before incision, and new marking pens were used when needed during the procedure. Results: Three of the 20 study pens (15%) demonstrated positive growth. All 3 pens grew species of Staphylococcus. None of the negative controls demonstrated growth, 6 of the 12 positive controls showed growth, and none of the blank dishes exhibited growth. Conclusion: This study found a 15% rate of surgical marking pen contamination by Staphylococcus during ACLR. It is recommended that the skin marking pen not be used for any further steps of the surgical case and be discarded once used. Clinical Relevance: Infections after ACLR are rare but may result in significant morbidity, and all measures to reduce them should be pursued. Surgeons performing ACLR should dispose of the surgical marking pen after skin marking and before intraoperative use such as graft markup.
Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1
VanLith, Caitlin J. , Guthman, Rebekah M., Nicolas, Clara T., Allen, Kari L. , Du, Zeji , Joo, Dong Jin , Nyberg, Scott L. , Lillegard, Joseph B. , VanLith, Caitlin, Guthman, Rebekah, Allen, Kari, Hickey, Raymond D, Hickey, Raymond

Mayo Clinic

Human Gene Therapy | May 16, 2018 | Volume: 29 | Issue: 11 | Pages: 1315-1326

10.1089/hum.2017.252 | PMID 29764210 Get It

Anti-infective chemoprophylaxis after solid-organ transplantation
Deziel, Paul J. , Razonable, Raymund, Razonable, Raymund R.

Mayo Clinic

Expert Review of Clinical Immunology | May 15, 2018 | Volume: 14 | Issue: 6 | Pages: 469-479

10.1080/1744666x.2018.1476852 | PMID 29764228 Get It

Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations
Kapoor, Ekta , Benrubi, Daniel, Faubion, Stephanie S.

Mayo Clinic

Clinical Obstetrics & Gynecology | May 15, 2018 | Volume: 61 | Issue: 3 | Pages: 488-495

10.1097/grf.0000000000000381 | PMID 29762148 Get It

Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.